T1	Participants 106 134	patients with liver failure]
T2	Participants 290 317	subjects with liver failure
T3	Participants 485 589	174 MARS treatment sessions for 146 patients with liver failure and prothrombin time activity percentage
T4	Participants 1901 1938	2 cases of severe bleeding after MARS
